A carregar...
Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria
Accurate appraisal of treatment response in metastatic castrate-resistant prostate cancer (mCRPC) is challenging in view of remarkable tumor heterogeneity and the available choices among many established and novel therapeutic approaches. The purpose of this single-center prospective study was to eva...
Na minha lista:
| Publicado no: | Theranostics |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7053201/ https://ncbi.nlm.nih.gov/pubmed/32194866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.39838 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|